SYNTHETIC BLOOD CLOT
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Apr 11, 2024
app pub date -
Oct 6, 2023
filing date -
Oct 7, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A synthetic blood clot and its corresponding method of formulation are described that provide a thrombus simulant capable of being used in synthetic biological pathways, such as for surgery training and/or simulation testing purposes. In one example embodiment, non-biohazardous ingredients such as one or more hydrogels, other thickening agents, coloring agents, and water are combined to form the thrombus simulant. A radiolucent agent may be provided to permit visualization of the thrombus simulant under certain imaging techniques, such as x-rays.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully